---
title: "Sportradar Group AG Stock 12‑Month Price Target Cut to $20.11, Implies 63% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294763568.md"
description: "Sportradar Group AG's 12-month average price target was lowered from $20.28 to $20.11 by 22 analysts, with forecasts ranging between $13.99 and $38.01. Based on the August 3 closing price, this implies a 63% upside potential. The consensus rating remains 'Buy', comprising 18 Buy ratings, 5 Hold ratings, and no Sell ratings among the covering analysts."
datetime: "2026-08-04T03:20:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294763568.md)
  - [en](https://longbridge.com/en/news/294763568.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294763568.md)
generator: "portal-rs"
---

# Sportradar Group AG Stock 12‑Month Price Target Cut to $20.11, Implies 63% Upside

-   According to estimates from 22 analysts, Sportradar Group AG stock's average price target has fallen from $20.28 to $20.11, with forecasts ranging from $13.99 to $38.01 per share
-   Based on the Aug. 3 closing price, the updated target implies approximately 63% potential upside
-   Consensus rating remains at “Buy” across 23 covering analysts, with 18 Buys, 5 Holds and 0 Sells

Explore more price target data and ratings for Sportradar Group AG on the , and track all previous and future analyst recommendations for Sportradar Group AG in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [SRAD.US](https://longbridge.com/en/quote/SRAD.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Morgan Stanley Remains a Hold on Sportradar Group AG (SRAD)](https://longbridge.com/en/news/298318643.md)
- [Sportradar Group AG Stock 12‑Month Price Target Cut to $19.3, Implies 49% Upside](https://longbridge.com/en/news/294940405.md)
- [20/20 Biolabs gets Nasdaq notice over $2.5 million stockholders’ equity shortfall](https://longbridge.com/en/news/298639044.md)
- [Adlai Nortye: Buy Rating Reiterated as RAS-Targeted Pipeline Advances; $20 Price Target Maintained](https://longbridge.com/en/news/298344682.md)
- [Fastly CTO Artur Bergman disposes of $754,030 in common shares](https://longbridge.com/en/news/298364607.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**